Törüner M - Search Results

1

Effects of polymorphism in G2677T/A triallelic region of MDR1 gene in Turkish patients with inflammatory bowel disease.

Sapmaz A, Ozen Karatayli SC, Dağli U, Kiliç ZM, Törüner M, Celik Y, Ozkan M, Soykan I, Cetinkaya H, Ulker A, Ozden A, Bozdayi AM. Sapmaz A, et al. Among authors: toruner m. Turk J Gastroenterol. 2008 Sep;19(3):168-73. Turk J Gastroenterol. 2008. PMID: 19115152 Free article.

2

Is pain experienced during liver biopsy an important factor?

Soykan I, Toruner M, Sarioglu M, Idilman R. Soykan I, et al. Among authors: toruner m. J Clin Gastroenterol. 2002 Jul;35(1):102-3. doi: 10.1097/00004836-200207000-00026. J Clin Gastroenterol. 2002. PMID: 12080240 No abstract available.

3

Remission of severe aplastic anemia associated with hepatitis B virus infection after viral clearance: potential role of lamivudine.

Bozkaya H, Yurdaydin C, Törüner M, Arat M, Bozdayi AM, Erekul S, Cinar K, Koç H, Uzunalimoğlu O. Bozkaya H, et al. Among authors: toruner m. Dig Dis Sci. 2002 Aug;47(8):1782-5. doi: 10.1023/a:1016444611997. Dig Dis Sci. 2002. PMID: 12184530

4

Reversal of iron deficiency anemia in a patient with gastric antral vascular ectasia treated with cyproheptadine.

Soykan I, Toruner M, Idilman R, Ozden A. Soykan I, et al. Among authors: toruner m. J Clin Gastroenterol. 2003 Feb;36(2):183-4. doi: 10.1097/00004836-200302000-00021. J Clin Gastroenterol. 2003. PMID: 12544207 No abstract available.

5

Lamivudine prophylaxis for prevention of chemotherapy-induced hepatitis B virus reactivation in hepatitis B virus carriers with malignancies.

Idilman R, Arat M, Soydan E, Törüner M, Soykan I, Akbulut H, Arslan O, Ozcan M, Türkyilmaz AR, Bozdayi M, Karayalçin S, Van Thiel DH, Ozden A, Beksaç M, Akan H. Idilman R, et al. Among authors: toruner m. J Viral Hepat. 2004 Mar;11(2):141-7. doi: 10.1046/j.1365-2893.2003.00479.x. J Viral Hepat. 2004. PMID: 14996349 Clinical Trial.

6

Barrett's esophagus: prevalence and its relationship with dyspeptic symptoms.

Toruner M, Soykan I, Ensari A, Kuzu I, Yurdaydin C, Ozden A. Toruner M, et al. J Gastroenterol Hepatol. 2004 May;19(5):535-40. doi: 10.1111/j.1440-1746.2003.03342.x. J Gastroenterol Hepatol. 2004. PMID: 15086597

7

Lamivudine vs lamivudine and interferon combination treatment of HBeAg(-) chronic hepatitis B.

Yurdaydin C, Bozkaya H, Cetinkaya H, Sahin T, Karaoğuz D, Törüner M, Erkan O, Heper AO, Erden E, Bozdayi AM, Uzunalimoğlu O. Yurdaydin C, et al. Among authors: toruner m. J Viral Hepat. 2005 May;12(3):262-8. doi: 10.1111/j.1365-2893.2005.00566.x. J Viral Hepat. 2005. PMID: 15850466 Clinical Trial.

8

The prevalence of extraintestinal manifestations and HLA association in patients with inflammatory bowel disease.

Turkcapar N, Toruner M, Soykan I, Aydintug OT, Cetinkaya H, Duzgun N, Ozden A, Duman M. Turkcapar N, et al. Among authors: toruner m. Rheumatol Int. 2006 May;26(7):663-8. doi: 10.1007/s00296-005-0044-9. Epub 2005 Sep 1. Rheumatol Int. 2006. PMID: 16136311

9

The effect of rabeprazole alone or in combination with H2 receptor blocker on intragastric pH: a pilot study.

Törüner M, Bektaş M, Cetinkaya H, Soykan I, Ozden A. Törüner M, et al. Turk J Gastroenterol. 2004 Dec;15(4):225-8. Turk J Gastroenterol. 2004. PMID: 16249975 Free article. Clinical Trial.

10

Factor V Leiden, prothrombin G20210A and MTHFR gene mutations in inflammatory bowel disease.

Törüner M, Erkan O, Soykan I, Bozdayi M, Cetinkaya H, Yurdaydin C, Uzunalimoğlu O, Ozden A. Törüner M, et al. Turk J Gastroenterol. 2004 Dec;15(4):250-2. Turk J Gastroenterol. 2004. PMID: 16249980 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

76 results

Search Page

Filters